to nalidixic acid by mutation in gyrA gene which replace nalidixic acid from the target site in gyrase A 5,3 . These nalidixic acid resistant Salmonella are also less responsive to ciprofloxacin due to less hydrogen bonding formed between ciprofloxacin and altered gyrase A. Resistance of Salmonella to nalidixic acid is mediated by alteration of amino acid in DNA gyrase which is result of mutation in gyrA and gyrB chromosomal genes and by alteration of amino acid in tropoisomerase which is result of mutation in parE and perC genes or by decreased permeability of drug or over-expression of efflux pump. However, mutation in gyrA gene is more common than gyrB, parE and perC genes 6 . Resistance mutations in gyrA gene is clustered in a region of gene product 67-106 amino acids called quinolone resistancedetermining region and most common mutations associated with quinolone resistance are located in amino acid, serine-83 or aspartic acid-87 7 . Single mutation in gyrA gene (either amino acid serine-83 or aspartic acid-87) is associated with resistance to nalidixic acid and decreased susceptibility to INTRODUCTION Enteric fever (typhoid and paratyphoid fever) is an endemic disease in developing countries 1 . The etiological agent of typhoid fever is Salmonella typhi and paratyphoid fevers are Salmonella paratyphi A, B and C 2 . Among these Salmonella, Salmonella typhi and Salmonella paratyphi A are mainly responsible for enteric fever. Antibiotic is the main therapeutic option for the treatment of enteric fever and mortality rate may reach up to 30% in the absence of effective antibiotic therapy 3 . Since Salmonella are resistant to conventional antibiotics (ampicillin, chloramphenicol and cotrimoxazole), ciprofloxacin and ofloxacin had been the drugs of choice in Bangladesh4. But rampant use of ciprofloxacin made Salmonella typhi and Salmonella paratyphi A resistant Total 323 blood samples were collected from suspected enteric fever patients from medicine and paediatric units of RMC hospital and cultured on brain heart infusion broth for isolation of Salmonella.
INTRODUCTION
Enteric fever (typhoid and paratyphoid fever) is an endemic disease in developing countries 1 . The etiological agent of typhoid fever is Salmonella typhi and paratyphoid fevers are Salmonella paratyphi A, B and C 2 . Among these Salmonella, Salmonella typhi and Salmonella paratyphi A are mainly responsible for enteric fever. Antibiotic is the main therapeutic option for the treatment of enteric fever and mortality rate may reach up to 30% in the absence of effective antibiotic therapy 3 . Since Salmonella are resistant to conventional antibiotics (ampicillin, chloramphenicol and cotrimoxazole), ciprofloxacin and ofloxacin had been the drugs of choice in Bangladesh4. But rampant use of ciprofloxacin made Salmonella typhi and Salmonella paratyphi A resistant 25922 strain of Escherechia coli to assess the quality of the test. Disc diffusion test was interpreted according to CLSI (2013) and European Committee on Antimicrobial Susceptibility Testing, 2015.
Preservation of bacteria:
The bacteria was streaked on nutrient agar slope and incubated at 37°C. When visible growth was observed, sterile liquid paraffin was poured on slope to cover the agar. The tube containing growth was then preserved at 4°C 10 .
Detection of gyrA gene by polymerase chain reaction: Formation of pellet of Salmonalla 11 : The nalidixic acid resistant and sensitive Salmonella typhi and Salmonella paratyphi A were tested for gyrA gene by PCR using previously used primer, forward 5 ' -TGTCCGAGATGGCCTGAAGC-3 ' reverse 5 ' -CGTTGATGACTTCCGTCAG-3 ' . The bacteria were cultured in brain heart infusion broth within micro centrifuge tube and incubated at 37°C for 24 hours. The microcentrifuge tube was centrifuged at 4000 x g for 10 minutes and supernatant was discarded. The pellets were then preserved at -20°C for DNA extraction.
DNA extraction:
The Salmonella pellets were suspended with 300µl of sterile distilled water and vortexed well. The microcentrifuge tube was placed on heat block at 100°C for 10 minutes and then immediately placed on ice block for 5 minutes. The microcentrifuge tube was then centrifuged at 13000 x g at 4°C for 6 minutes and the supernatant was transferred to another fresh microcentrifuge tube. This supernatant contains extracted DNA which was used as template DNA for PCR.
Mixing of master mix, primer and extracted DNA: A total of 25µl of reaction mixture was prepared in a PCR tube by using 12.5µl of master mix (a mixture of dNTP, taq polymerase, MgCl 2 , PCR buffer), 1 µl of forward primer, 1 µl of reverse primer, 3 µl of extracted DNA and 7.5µl nuclease free water.
Amplification in thermal cycler:
After initial denaturation at 94°C for 3 minutes, total 30 cycles of each cycle consists of denaturation at 94°C for one minute, annealing at 55°C for one minute and extension at 72°C for one minute with one cycle of final extension at 72°C for 10 minutes.
Gel electrophoresis: Electrophoresis of the amplicons was done at 100 volts for 35 minutes in 1X Tris-borate-EDTA buffer in 1.5% agar gel, stained with ethidium bromide and visualized by UV transilluminator. Band size was assessed by comparing with bands of 100 bp DNA ladder. fluoroquinolone 8 .
A good number of quinolone resistant Salmonella have been detected in Rajshahi Medical College Hospital but the reason behind this resistance has not been clear. So this study has been carried out to find out the mutations in gyrA gene from nalidixic acid resistant Salmonella.
MATERIALS AND METHODS
Microbiological study was carried out in the department of microbiology of Rajshahi Medical College (RMC) and PCR and sequencing was performed in the department of microbiology of Dhaka Medical College from August 2014 to July 2015. Blood samples were collected from 323 suspected enteric fever patients of both outpatient and inpatient departments of medicine and pediatric units of RMC hospital. Patients presented with fever > _ 102° F for more than 3 days and associated constipations, diarrhea, diffuse abdominal pain or coated tongue were clinically diagnosed as enteric fever and were included in this study.
About 5ml blood from adult and 1 to 5 ml blood (according to body weight) from young children were collected following preparation of the skin site with 70% alcohol, then providone iodine and transferred to blood culture bottles containing 50 and 25ml brain heart infusion broth respectively. The bottles containing blood were sent to laboratory promptly and incubated at 37°C.
The culture bottles were examined daily for visible turbidity and subcultured every alternate day on blood, MacConkey and Salmonella-Shigella agar up to 14 days. Bacterial growth was indicated by the presence of turbidity in the media. If visible growth was detected a little amount of the broth was dispensed by sterile disposable syringe and inoculated on blood, MacConkey and Salmonella-Shigella agar and incubated at 37°C for 24 hours. If growth observed on blood, MacConkey and Salmonella-Shigella agar media, bacteria were identified as Salmonella typhi and Salmonella paratyphi A by nonlactose fermenting colony on MacConkey agar media, gram negative bacilli in Gram stained smear, motile, indole, urease and citrate negative, alkaline slant and acid butt with or without H2S production in triple sugar iron agar media, negative oxidase test and finally agglutination with Salmonella polyvalent O and specific H antisera. Antimicrobial susceptibility was determined by modified Kirby-Bauer disc diffusion method and following Clinical and Laboratory Standards Institute (CLSI) guide line using Mueller-Hinton agar plate 9 . Both Salmonella typhi and paratyphi A were tested for susceptibility with ciprofloxacin (5µg), ofloxacin (5µg) and nalidixic acid (30µg). A representative disc of each batch was tested with ATCC
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S. typhi n(%)
S. paratyphi A n(%) Fig-3 . Partial DNA sequence of quinolone resistancedetermining region of gyrA gene of nalidixic acid resistant Salmonella typhi and Salmonella paratyphi A with highlighted area of mutation at amino acid position 83. Due to point mutation, cytosine ( C ) is substituted with thymine (T), as a result, TCC, which is coded for serine was replaced by TTC, which is coded for phenylalanine. fig.3 ) showed mutation at amino acid position 83(TCC, coded for serine was replaced by TTC, coded for phenylalanine). None of the nalidixic acid sensitive strains showed mutation of amino acid at position 83 (Table-2) . mutation at position 83 of gyrA gene was observed in 78.9 to 100% Salmonella typhi strains but dissimilar with a report from China 26 where 30 % Salmonella were found mutated at amino acid position 87 of gyrA gene. For Salmonella paratyphi A, similar data were reported from different regions where 95 -100% Salmonella paratyphi A were mutated at amino acid position 83 27, 28 . In contrast to the present findings it was reported from China that 16% Salmonella paratyphiA were mutated at amino acid position 87 of gyrA gene 28 . The amino acids serine at position 83 and aspartic acid at position 87 of gyrase are necessary for sensitivity with nalidixic acid 29 .
We, however, did not find any mutation at position 87.
CONCLUSION
Salmonella paratyphi A was predominant over Salmonella typhi as a causative agent of enteric fever. Most of the Salmonella typhi and 100% Salmonella paratyphi A were resistant to nalidixic acid and the resistance was due to mutation at amino acid position 83 of gyrase protein by replacing serine with phenylalanine.
Increased isolation of nalidixic acid resistant Salmonella indicates that fluoroquinolones are no more treatment option for enteric fever.
In this study culture yielded growth of Salmonella typhi in 3.41% and S.paratyphi A in 5.88% of the clinically suspected enteric fever cases which is similar to other studies in Nepal 12 and India 13 .
In consistent with other studies of India 14, 15 , 72.73% Salmomella typhi were resistant to nalidixic acid in the present study. In addition, 18.18% Salmonella typhi were resistant to ciprofloxacin which is similar to published data from India 3 and Nepal 16 . In contrast, 34.5% ciprofloxacin resistant strains were reported from New Delhi 17 . About 9.09% Salmonella typhi were resistant to ofloxacin in this study which agrees with other reports from India 14,18 but does not correlate with data of Pakistan where 88.2% Salmonella were resistant to ofloxacin 19 . The dissimilarity of resistance pattern of Salmonella typhi to ciprofloxacin and ofloxacin between our study and other studies might be due to difference in use of antibiotics to treat enteric fever in different countries and different areas of the same country. Moreover, these are orally administered drugs which are prescribed by the physicians and used by the people due to its easy availability for treatment of other infections, which may play role in development of drug resistance against Salmonella.
All (100%) Salmonella paratyphi A were resistant to nalidixic acid in this study which is similar to other studies in India and Nepal 17, 20 . Dissimilarity was noted by Shetty et al (2012) in India who reported 62.5% Salmonella paratyphi A were resistant to nalidixic acid. About 15.79% strains were resistant to ciprofloxacin which is similar to studies in India 3, 21 .
In contrast, 1.56% strains resistant to ciprofloxacin was reported from India 22 . Ofloxacin was ineffective in 21.05% Salmonella paratyphi strains in this study which is similar with a study in Pakistan 23 but does not correlate with data of another study in Pakistan 19 where 83.9% Salmonella paratyphi were resistant to ofloxacin.
From these findings it seems that proportion of ciprofloxacin resistance is less in vitro, but as most of the Salmonella typhi and 100% Salmonella paratyphi A are resistant to nalidixic acid in this study, so ciprofloxacin and other quinolones will not be effective in vivo.
In both Salmonella typhi and Salmonella paratyphi A, gyrA gene was mutated on amino acid position 83 and serine was replaced by phenylalanine. This data is similar to data reported from Vietnam 24 , some parts of Asia 25 where same
